Myeloproliferative Neoplasms Rounds
February 5, 2025
Format
New Live, In-Person Event
*Pre-registration required
Interactive continuing medical education activity for healthcare professionals in New York and the surrounding areas to discuss myeloproliferative neoplasms (MPNs) updates and challenges in treatment.
Target Audience
This activity is intended for hematologists-oncologists, medical oncologists, physician associates, advanced practice providers, nurses and pharmacists involved in the care of patients with Myeloproliferative Neoplasms (MPNs).
Agenda
6:30 PM – Dinner and Networking
7:00 PM – Welcome and Overview of Program
John Mascarenhas, MD
7:05 PM – Overview of LLS Resources
LLS Staff
7:10 PM – Case Presentation and Discussion on Management of "Lower-risk" Essential Thrombocythemia (ET) and Polycythemia Vera (PV)
Ghaith Abu-Zeinah, MD and Franco Castillo Tokumori, MD
7:35 PM – Case Presentation and Discussion on Optimizing Jak Inhibitor Therapy in Myelofibrosis
Noa Rippel, MD and Megan Metzger, MD
8:00 PM – Case Presentation and Discussion on Targeting Mastocytosis: Current and Emerging Strategies in Diagnosis, Risk Stratification and Treatment
Katherine Linder, MD and Sarvarinder Gill, MD
8:25 PM – Case Presentation and Discussion on Newly Diagnosed Chronic Myeloid Leukemia (CML): Pros and Cons of the Approved Drugs
Karen Seiter, MD and Snigdha Ghanta, MBBS
8:50 PM – Q&A, Discussion and Wrap-up
All Faculty
9:00 PM – Conclusion
John Mascarenhas, MD
Educational Objectives
At the conclusion of this activity, participants will be better able to:
- Apply diagnostic criteria for a correct diagnosis and grade
- Explain the latest treatment options for myeloproliferative neoplasms (MPNs), including updates on clinical trials
- Identify disparities and challenges in diagnosis and treatment of MPNs
- Describe side effects of treatment and management strategies
- Identify resources for patient education and support
Advisory Group
John Mascarenhas, MD (Chair)
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
Ghaith Abu-Zeinah, MD
Weill Cornell Medicine
New York, NY
Swati Goel, MD
Albert Einstein College of Medicine
Bronx, NY
Marina Kremyanskaya MD PhD
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
James McCloskey, MD
John Theurer Cancer Center
Hackensack University School of Medicine
Hackensack, NJ
Raajit K. Rampal, MD, PhD
Memorial Sloan Kettering Cancer Center
New York, NY
Karen Seiter, MD
New York Medical College
Valhalla, New York
Faculty
John Mascarenhas, MD (Chair)
Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY
Ghaith Abu-Zeinah, MD
Weill Cornell Medicine
New York, NY
Franco Castillo Tokumori, MD
New York Presbyterian Hospital - Weill Cornell Medicine
New York, NY
Snigdha Ghanta, MBBS
Westchester Medical Center
Valhalla, NY
Sarvarinder Gill, MD
John Theurer Cancer Center
Hackensack University Medical Center
Hackensack, NJ
Katherine Linder, MD
John Theurer Cancer Center
Hackensack Meridian Medical Center
Hackensack, NJ
Megan Metzger, MD
Icahn School of Medicine at Mount Sinai
New York, NY
Noa Rippel, MD
Icahn School of Medicine at Mount Sinai
New York, NY
Karen Seiter, MD
New York Medical College
Valhalla, NY
Accreditation, Credit and Support
In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute Inc and The Leukemia & Lymphoma Society. Medical Learning Institute Inc is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Medical Learning Institute Inc (MLI) designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit
For Physicians requesting MOC credit, the post-test and evaluation are required in their entirety as well as your ABIM ID number, DOB (MM/DD), and a score of 70% or higher is needed to obtain MOC credit.
Physician Associate
Medical Learning Institute Inc has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 2.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Nursing Continuing Professional Development Contact Hours
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 2.0 continuing education contact hour through the California Board of Registered Nursing.
Pharmacy
Medical Learning Institute Inc designates this application-based continuing education activity for 2.0 contact hours (0.2 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: JA0007322-9999-25-006-L01-P
Type of Activity: Application
Method of Participation
There are no fees for participating in or receiving credits for this CE activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.
In order to receive credit, learners must participate in the entire CE activity, complete the activity evaluation form and return it to staff at the end of the program. A certificate of completion will be emailed within 30 days of receipt. If you have questions regarding the receipt of your certificate, please contact us via email at ndane@mlieducation.org.
For Pharmacists, Medical Learning Institute Inc will accept your completed evaluation form for up to 30 days post-activity and will report your participation to the NABP only if you provide your NABP e-Profile number and DOB (MM/DD). Within 6 weeks, you can view your participation record at the NABP website: https://nabp.pharmacy/
Providers
This activity is provided by The Leukemia & Lymphoma Society and Medical Learning Institute Inc in collaboration with the Association of Cancer Care Centers™ (ACCC).
Supporters
There is no commercial support associated with this activity.
For questions, concerns, or assistance for people with disabilities or grievances, please contact us at: profeducation@LLS.org.